P137. 5 year budget impact analysis of CT-P13 (Infliximab) for the treatment of Crohn's Disease in UK, Italy and France
2015 ◽
Vol 9
(suppl 1)
◽
pp. S144-S145
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 10
(1)
◽
pp. 19-28
Keyword(s):
Keyword(s):